omnicyte.com | Home | Finding Targeted Life-Saving Treatments For Patients With

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.omnicyte.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Home \| Finding Targeted Life-Saving Treatments For Patients With
Description	OmniCyte is a pre-clinical biotech company addressing significant unmet needs in
Keywords	N/A

Server Information

WebSite	omnicyte.com
Host IP	185.230.63.171
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

omnicyte.com Valuation

US$253,022

Last updated: 2023-05-07 19:22:06

omnicyte.com has Semrush global rank of 41,831,554. omnicyte.com has an estimated worth of US$ 253,022, based on its estimated Ads revenue. omnicyte.com receives approximately 29,195 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, omnicyte.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$253,022
Daily Ads Revenue	US$234
Monthly Ads Revenue	US$7,007
Yearly Ads Revenue	US$84,082
Daily Unique Visitors	1,947
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
omnicyte.com.	A	3599	IP: 185.230.63.171
omnicyte.com.	A	3599	IP: 185.230.63.186
omnicyte.com.	A	3599	IP: 185.230.63.107
omnicyte.com.	NS	86400	NS Record: ns1.wixdns.net.
omnicyte.com.	NS	86400	NS Record: ns0.wixdns.net.
omnicyte.com.	MX	3600	MX Record: 10 mx1.netsolmail.net.

HtmlToTextCheckTime:2023-05-07 19:22:06

top of page Home About Us Development Presentation Contact Finding Targeted Life-Saving Treatments For Patients With Cancer OmniCyte is a preclinical stage biotechnology company focused on developing targeted treatments for unmet needs in cancer therapy. OmniCyte is developing its own proprietary Immuno-Oncology Platform Technology for Recombinant targeted immunomodulators (co-stimulators) Ovarian cancer indication (fifth greatest cancer killer in women) Small Cell Lung Cancer (the most deadly human malignancies) and multiple additional indications (Non Small Cell Lung Cancer, Glioma, cancer stem cells, pancreatic, prostate, leukemia) We have a strong management team and deep bench of advisors and collaborators. Our funding has been provided by Connecticut Innovations, angel investors, NCI SBIR & STTR and LLS Translational Research grants and the founders. Research & Development Developing a targeted immune-oncological therapeutic platform. OmniCyte Presentation Detailed slide

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Thu, 28 Oct 2021 14:57:54 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.omnicyte.com/
strict-transport-security: max-age=120
x-wix-request-id: 1635433074.180621014237729411
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=42
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgAmI6NXu6WfqLI/M7f8tcV,m0j2EEknGIVUW/liY8BLLkiHzpTYSDRA7u88Ic3Fde7F+NHRbelhY0dsZwjDYnLI,2d58ifebGbosy5xc+FRaltvEuACzbtSQeR97jBe4srTn2U05zyWhm35LC4gbT13lxqCNlGvv0HKnqyoZcy84pQ==,2UNV7KOq4oGjA5+PKsX47DqQgZ4euQCNWDy58PBtjlYfbJaKSXYQ/lskq2jK6SGP,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,LWZ6Tylfijl32cnmU7+qjEMbF9TVlya+ocPvXHfUrwIaWyug/ZdHQ36uOAkr89T0,wjXkXN74v+Dcwxj+Ualvvnwix+bxiykGU1oyzfbFBVMe0NKesr2K1gj9EVCBkmFH
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Thu, 28 Oct 2021 14:57:54 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1635433074.32758173685413201
content-language: en
strict-transport-security: max-age=120
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMclMQzbR0A/m5vNbgNVf0Qw,qquldgcFrj2n046g4RNSVI5y0OKACGwHEq+Bmxf53RlYgeUJqUXtid+86vZww+nL,2d58ifebGbosy5xc+FRaltOywjf0W5dErSmBUaQdWDbBJ4bMpVGPUBJu+co/8Jm7Sf524lPwTgDbn82fURSkbhzpqaSPDnTVeYhhgijRN6w=,2UNV7KOq4oGjA5+PKsX47O8u2A3urGBG2TQyUo3GmetYgeUJqUXtid+86vZww+nL,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,JLaio/7uvfP647F5CQsGZUTaiG2Bxo6WEsws+pTQetwaWyug/ZdHQ36uOAkr89T0,wjXkXN74v+Dcwxj+Ualvvtfa9zHNz1/9wP3AOjcmBjGvllg16gNaZsBKgWXqE67w,JLaio/7uvfP647F5CQsGZUTaiG2Bxo6WEsws+pTQetwaWyug/ZdHQ36uOAkr89T0,qJS91GsscGZlb16v+8nwmKNyh9qWrhjoO4wkqfb5zAEPUN6zYCeYUhP+LoeE7OiY,LoUK8/saGAmOxZWtpubo2oL0+k1UdVRmz30uCOJ2so0t8NueKG3zQ4Vf7GsSLMJdY1o9R/g+VknE96cPLd2QNA==,qJS91GsscGZlb16v+8nwmKNyh9qWrhjoO4wkqfb5zAEPUN6zYCeYUhP+LoeE7OiY,WcrWvzU6+v56AFbpVWES8pL0jbdRovz6Z1QvJknjatMaWyug/ZdHQ36uOAkr89T0,/a5ccLSK1HEmwPNg/x6OukIT+c5HqyHveWvXmN7dchrjTXbA9us0BUieg4TaMpLJySuLWwz1o7GJ+/b090We5ez2UHp7wJxGQuS2ol9OzT0=
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=usc1_g; Max-Age=20; Expires=Thu, 28 Oct 2021 14:58:14 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=usc1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

omnicyte.com Whois Information

Domain Name: OMNICYTE.COM
Registry Domain ID: 87629103_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-05-26T18:12:54Z
Creation Date: 2002-06-18T03:34:04Z
Registry Expiry Date: 2026-06-18T03:34:04Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS0.WIXDNS.NET
Name Server: NS1.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-16T07:07:47Z <<<

omnicyte.com valuation and analysis